5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.38▲ | 1.39▲ | 1.40▲ | 1.30▲ | 1.23▲ |
MA10 | 1.39▲ | 1.38▲ | 1.37▲ | 1.21▲ | 1.13▲ |
MA20 | 1.36▲ | 1.32▲ | 1.30▲ | 1.13▲ | 1.25▲ |
MA50 | 1.30▲ | 1.26▲ | 1.23▲ | 1.08▲ | 1.25▲ |
MA100 | 1.25▲ | 1.18▲ | 1.12▲ | 1.26▲ | 1.16▲ |
MA200 | 1.18▲ | 1.09▲ | 1.08▲ | 1.31▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.003▲ | 0.009▲ | 0.038▲ | 0.017▲ |
RSI | 63.639▲ | 65.249▲ | 66.178▲ | 70.082▲ | 54.382▲ |
STOCH | 44.040 | 76.389 | 90.278▲ | 85.855▲ | 65.801 |
WILL %R | -13.043▲ | -12.500▲ | -6.000▲ | -10.007▲ | -6.167▲ |
CCI | 89.583 | 98.922 | 81.721 | 171.274▲ | 114.463▲ |
Thursday, June 12, 2025 02:15 PM
Quince Therapeutics, Inc. (Nasdaq: QNCX) ("Quince" or the "Company"), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, ...
|
Thursday, June 12, 2025 07:15 AM
Inc. (Nasdaq: QNCX) (“Quince” or the “Company”), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases ...
|
Saturday, May 24, 2025 02:53 PM
Currently serving as the CEO of Judo Bio and a board member of Quince Therapeutics, Inc. (NASDAQ:QNCX), Dr. Patni brings a wealth of experience to BioXcel Therapeutics. His appointment comes at a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 1.385 | 1.405 | 1.365 | 1.405 | 202,580 |
13/06/25 | 1.20 | 1.45 | 1.19 | 1.43 | 656,349 |
12/06/25 | 1.27 | 1.27 | 1.15 | 1.20 | 1,427,223 |
11/06/25 | 1.20 | 1.28 | 1.19 | 1.25 | 156,517 |
10/06/25 | 1.185 | 1.20 | 1.185 | 1.195 | 85,469 |
09/06/25 | 1.19 | 1.20 | 1.16 | 1.17 | 81,520 |
06/06/25 | 1.20 | 1.21 | 1.155 | 1.17 | 191,200 |
05/06/25 | 1.10 | 1.21 | 1.10 | 1.19 | 622,243 |
04/06/25 | 1.08 | 1.09 | 1.06 | 1.09 | 85,519 |
03/06/25 | 1.07 | 1.08 | 1.04 | 1.05 | 68,404 |
|
|
||||
|
|
||||
|
|